Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice

Francesco Lozupone, Daniela Pende, Vito Lelio Burgio, Chiara Castelli, Massimo Spada, Massimo Venditti, Francesca Luciani, Luana Lugini, Cristina Federici, Carlo Ramoni, Licia Rivoltini, Giorgio Parmiani, Filippo Belardelli, Paola Rivera, Stefania Marcenaro, Lorenzo Moretta, Stefano Fais

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Natural killer (NK) cells were first identified for their ability to kill tumor cells of different origin in vitro. Similarly, γδ T lymphocytes display strong cytotoxic activity against various tumor cell lines. However, the ability of both the NK and γδ cells to mediate natural immune response against human malignant tumors in vivo is still poorly defined. Severe combined immunodeficient (SCID) mice have been successfully engrafted with human tumors. In this study, the antitumor effect of local as well as of systemic treatments based on NK cells or Vδ1 or Vδ2 γ/δ T lymphocytes against autologous melanoma cells was investigated in vivo. The results show that all three of the populations were effective in preventing growth of autologous human melanomas when both tumor and lymphoid cells were s.c. inoculated at the same site. However, when lymphoid cells were infused i.v., only NK cells and Vδ1 γ/δ T lymphocytes could either prevent or inhibit the s.c. growth of autologous melanoma. Accordingly, both NK cells and Vδ1 γδ T lymphocytes could be detected at the s.c. tumor site. In contrast, Vδ2 γδ T lymphocytes were only detectable in the spleen of the SCID mice. Moreover, NK cells maintained their inhibitory effect on tumor growth even after discontinuation of the treatment. Indeed they were present at the tumor site for a longer period. These data support the possibility to exploit NK cells and Vδ1 γδ T lymphocytes in tumor immunotherapy. Moreover, our study emphasizes the usefulness of human tumor/SCID mouse models for preclinical evaluation of immunotherapy protocols against human tumors.

Original languageEnglish
Pages (from-to)378-385
Number of pages8
JournalCancer Research
Volume64
Issue number1
DOIs
Publication statusPublished - Jan 1 2004

Fingerprint

Natural Killer T-Cells
SCID Mice
Heterografts
Melanoma
Natural Killer Cells
Growth
Neoplasms
T-Lymphocytes
Immunotherapy
Lymphocytes
Tumor Cell Line
Spleen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice. / Lozupone, Francesco; Pende, Daniela; Burgio, Vito Lelio; Castelli, Chiara; Spada, Massimo; Venditti, Massimo; Luciani, Francesca; Lugini, Luana; Federici, Cristina; Ramoni, Carlo; Rivoltini, Licia; Parmiani, Giorgio; Belardelli, Filippo; Rivera, Paola; Marcenaro, Stefania; Moretta, Lorenzo; Fais, Stefano.

In: Cancer Research, Vol. 64, No. 1, 01.01.2004, p. 378-385.

Research output: Contribution to journalArticle

Lozupone, F, Pende, D, Burgio, VL, Castelli, C, Spada, M, Venditti, M, Luciani, F, Lugini, L, Federici, C, Ramoni, C, Rivoltini, L, Parmiani, G, Belardelli, F, Rivera, P, Marcenaro, S, Moretta, L & Fais, S 2004, 'Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice', Cancer Research, vol. 64, no. 1, pp. 378-385. https://doi.org/10.1158/0008-5472.CAN-03-1501
Lozupone, Francesco ; Pende, Daniela ; Burgio, Vito Lelio ; Castelli, Chiara ; Spada, Massimo ; Venditti, Massimo ; Luciani, Francesca ; Lugini, Luana ; Federici, Cristina ; Ramoni, Carlo ; Rivoltini, Licia ; Parmiani, Giorgio ; Belardelli, Filippo ; Rivera, Paola ; Marcenaro, Stefania ; Moretta, Lorenzo ; Fais, Stefano. / Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice. In: Cancer Research. 2004 ; Vol. 64, No. 1. pp. 378-385.
@article{f0f8337528a944bb9cb937b3d62154e8,
title = "Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice",
abstract = "Natural killer (NK) cells were first identified for their ability to kill tumor cells of different origin in vitro. Similarly, γδ T lymphocytes display strong cytotoxic activity against various tumor cell lines. However, the ability of both the NK and γδ cells to mediate natural immune response against human malignant tumors in vivo is still poorly defined. Severe combined immunodeficient (SCID) mice have been successfully engrafted with human tumors. In this study, the antitumor effect of local as well as of systemic treatments based on NK cells or Vδ1 or Vδ2 γ/δ T lymphocytes against autologous melanoma cells was investigated in vivo. The results show that all three of the populations were effective in preventing growth of autologous human melanomas when both tumor and lymphoid cells were s.c. inoculated at the same site. However, when lymphoid cells were infused i.v., only NK cells and Vδ1 γ/δ T lymphocytes could either prevent or inhibit the s.c. growth of autologous melanoma. Accordingly, both NK cells and Vδ1 γδ T lymphocytes could be detected at the s.c. tumor site. In contrast, Vδ2 γδ T lymphocytes were only detectable in the spleen of the SCID mice. Moreover, NK cells maintained their inhibitory effect on tumor growth even after discontinuation of the treatment. Indeed they were present at the tumor site for a longer period. These data support the possibility to exploit NK cells and Vδ1 γδ T lymphocytes in tumor immunotherapy. Moreover, our study emphasizes the usefulness of human tumor/SCID mouse models for preclinical evaluation of immunotherapy protocols against human tumors.",
author = "Francesco Lozupone and Daniela Pende and Burgio, {Vito Lelio} and Chiara Castelli and Massimo Spada and Massimo Venditti and Francesca Luciani and Luana Lugini and Cristina Federici and Carlo Ramoni and Licia Rivoltini and Giorgio Parmiani and Filippo Belardelli and Paola Rivera and Stefania Marcenaro and Lorenzo Moretta and Stefano Fais",
year = "2004",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-03-1501",
language = "English",
volume = "64",
pages = "378--385",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice

AU - Lozupone, Francesco

AU - Pende, Daniela

AU - Burgio, Vito Lelio

AU - Castelli, Chiara

AU - Spada, Massimo

AU - Venditti, Massimo

AU - Luciani, Francesca

AU - Lugini, Luana

AU - Federici, Cristina

AU - Ramoni, Carlo

AU - Rivoltini, Licia

AU - Parmiani, Giorgio

AU - Belardelli, Filippo

AU - Rivera, Paola

AU - Marcenaro, Stefania

AU - Moretta, Lorenzo

AU - Fais, Stefano

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Natural killer (NK) cells were first identified for their ability to kill tumor cells of different origin in vitro. Similarly, γδ T lymphocytes display strong cytotoxic activity against various tumor cell lines. However, the ability of both the NK and γδ cells to mediate natural immune response against human malignant tumors in vivo is still poorly defined. Severe combined immunodeficient (SCID) mice have been successfully engrafted with human tumors. In this study, the antitumor effect of local as well as of systemic treatments based on NK cells or Vδ1 or Vδ2 γ/δ T lymphocytes against autologous melanoma cells was investigated in vivo. The results show that all three of the populations were effective in preventing growth of autologous human melanomas when both tumor and lymphoid cells were s.c. inoculated at the same site. However, when lymphoid cells were infused i.v., only NK cells and Vδ1 γ/δ T lymphocytes could either prevent or inhibit the s.c. growth of autologous melanoma. Accordingly, both NK cells and Vδ1 γδ T lymphocytes could be detected at the s.c. tumor site. In contrast, Vδ2 γδ T lymphocytes were only detectable in the spleen of the SCID mice. Moreover, NK cells maintained their inhibitory effect on tumor growth even after discontinuation of the treatment. Indeed they were present at the tumor site for a longer period. These data support the possibility to exploit NK cells and Vδ1 γδ T lymphocytes in tumor immunotherapy. Moreover, our study emphasizes the usefulness of human tumor/SCID mouse models for preclinical evaluation of immunotherapy protocols against human tumors.

AB - Natural killer (NK) cells were first identified for their ability to kill tumor cells of different origin in vitro. Similarly, γδ T lymphocytes display strong cytotoxic activity against various tumor cell lines. However, the ability of both the NK and γδ cells to mediate natural immune response against human malignant tumors in vivo is still poorly defined. Severe combined immunodeficient (SCID) mice have been successfully engrafted with human tumors. In this study, the antitumor effect of local as well as of systemic treatments based on NK cells or Vδ1 or Vδ2 γ/δ T lymphocytes against autologous melanoma cells was investigated in vivo. The results show that all three of the populations were effective in preventing growth of autologous human melanomas when both tumor and lymphoid cells were s.c. inoculated at the same site. However, when lymphoid cells were infused i.v., only NK cells and Vδ1 γ/δ T lymphocytes could either prevent or inhibit the s.c. growth of autologous melanoma. Accordingly, both NK cells and Vδ1 γδ T lymphocytes could be detected at the s.c. tumor site. In contrast, Vδ2 γδ T lymphocytes were only detectable in the spleen of the SCID mice. Moreover, NK cells maintained their inhibitory effect on tumor growth even after discontinuation of the treatment. Indeed they were present at the tumor site for a longer period. These data support the possibility to exploit NK cells and Vδ1 γδ T lymphocytes in tumor immunotherapy. Moreover, our study emphasizes the usefulness of human tumor/SCID mouse models for preclinical evaluation of immunotherapy protocols against human tumors.

UR - http://www.scopus.com/inward/record.url?scp=9144261113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144261113&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-03-1501

DO - 10.1158/0008-5472.CAN-03-1501

M3 - Article

VL - 64

SP - 378

EP - 385

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 1

ER -